Pasithea Therapeutics Corp. (KTTA) earnings
KTTA earnings moved a median of +0.01% by the close. Quarterly and annual KTTA reports and results, each read against the price at its own news timestamp. Back to the KTTA overview →
11 measured KTTA earnings events.
Where these KTTA earnings landedvs 10 measured KTTA earnings reactions
| Middle 50% of KTTA earnings reactions | -1.78% to +3.63% |
|---|---|
| Median reaction (to close) | +0.01% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 KTTA earnings events with a measured close landed between -1.78% and +3.63%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.55% | -1.85% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.51% | +0.00% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.70% | +4.48% | |
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.18% | +0.03% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +28.25% | +12.47% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.15% | -1.57% | |
| Form 10-Q Pasithea Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | -2.94% | |
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | — | -3.75% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | — | +1.06% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Pasithea Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.67% |
Keep exploring
More KTTA: analyst actions → · SEC filings → · KTTA overview →